Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search

Cardiovascular Pharmacology

Citations 341-350 of 1154 total displayed.

Past content (since Jan 1999):

Articles
Physiological Background of the Loss of Fractal Heart Rate Dynamics
Mikko P. Tulppo, Antti M. Kiviniemi, Arto J. Hautala, Mika Kallio, Tapio Seppänen, Timo H. Mäkikallio, and Heikki V. Huikuri
Circulation published July 11, 2005, doi:10.1161/CIRCULATIONAHA.104.523712 [Abstract]  

Articles
Statin Therapy May Be Associated With Lower Mortality in Patients With Diastolic Heart Failure. A Preliminary Report
Hidekatsu Fukuta, David C. Sane, Steffen Brucks, and William C. Little
Circulation published July 11, 2005, doi:10.1161/CIRCULATIONAHA.104.519876 [Abstract]  

Editorials
N-Terminal-Pro-B–Type Natriuretic Peptide: Universal Marker of Cardiovascular Risk?
A. Mark Richards and Christopher M. Frampton
Circulation 2005;112:9-11, doi:10.1161/CIRCULATIONAHA.105.551853 [Full text]  

Heart Failure
Effects of Candesartan on the Development of a New Diagnosis of Diabetes Mellitus in Patients With Heart Failure
Salim Yusuf, Jan B. Ostergren, Hertzel C. Gerstein, Marc A. Pfeffer, Karl Swedberg, Christopher B. Granger, Bertil Olofsson, Jeffrey Probstfield, John V. McMurray on behalf of the Candesartan in Heart Failure—Assessment of Reduction in Mortality and Morbidity Program (CHARM) Investigators
Circulation 2005;112:48-53; published online before print as doi:10.1161/CIRCULATIONAHA.104.528166 [Abstract] [Full text]  

Editorials
Defective Ryanodine Receptor Interdomain Interactions May Contribute to Intracellular Ca2+ Leak: A Novel Therapeutic Target in Heart Failure
Stephan E. Lehnart, Xander H.T. Wehrens, and Andrew R. Marks
Circulation 2005;111:3342-3346, doi:10.1161/CIRCULATIONAHA.105.551861 [Full text]  

Epidemiology
Pharmacogenetic Association of the Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism on Blood Pressure and Cardiovascular Risk in Relation to Antihypertensive Treatment: The Genetics of Hypertension-Associated Treatment (GenHAT) Study
Donna K. Arnett, Barry R. Davis, Charles E. Ford, Eric Boerwinkle, Cathie Leiendecker-Foster, Michael B. Miller, Henry Black, and John H. Eckfeldt
Circulation 2005;111:3374-3383; published online before print as doi:10.1161/CIRCULATIONAHA.104.504639 [Abstract] [Full text]  

Heart Failure
Changes in Ventricular Size and Function in Patients Treated With Valsartan, Captopril, or Both After Myocardial Infarction
Scott D. Solomon, Hicham Skali, Nagesh S. Anavekar, Mikhail Bourgoun, Stale Barvik, Jalal K. Ghali, J. Wayne Warnica, Margarita Khrakovskaya, J. Malcolm O. Arnold, Yuri Schwartz, Eric J. Velazquez, Robert M. Califf, John V. McMurray, and Marc A. Pfeffer
Circulation 2005;111:3411-3419; published online before print as doi:10.1161/CIRCULATIONAHA.104.508093 [Abstract] [Full text]  

Cardiovascular Surgery
Renoprotective Action of Fenoldopam in High-Risk Patients Undergoing Cardiac Surgery: A Prospective, Double-Blind, Randomized Clinical Trial
Tiziana Bove, Giovanni Landoni, Maria Grazia Calabrò, Giacomo Aletti, Giovanni Marino, Elisa Cerchierini, Giuseppe Crescenzi, and Alberto Zangrillo
Circulation 2005;111:3230-3235, doi:10.1161/CIRCULATIONAHA.104.509141 [Abstract] [Full text]  

Articles
Changes in Ventricular Size and Function in Patients Treated With Valsartan, Captopril, or Both After Myocardial Infarction
Scott D. Solomon, Hicham Skali, Nagesh S. Anavekar, Mikhail Bourgoun, Stale Barvik, Jalal K. Ghali, J. Wayne Warnica, Margarita Khrakovskaya, J. Malcolm O. Arnold, Yuri Schwartz, Eric J. Velazquez, Robert M. Califf, John V. McMurray, and Marc A. Pfeffer
Circulation published June 20, 2005, doi:10.1161/CIRCULATIONAHA.104.508093 [Abstract]  

Articles
Pharmacogenetic Association of the Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism on Blood Pressure and Cardiovascular Risk in Relation to Antihypertensive Treatment. The Genetics of Hypertension-Associated Treatment (GenHAT) Study
Donna K. Arnett, Barry R. Davis, Charles E. Ford, Eric Boerwinkle, Cathie Leiendecker-Foster, Michael B. Miller, Henry Black, and John H. Eckfeldt
Circulation published June 20, 2005, doi:10.1161/CIRCULATIONAHA.104.504639 [Abstract]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116

* Subspecialty Collections Home

* Show  Cardiovascular Pharmacology
 collections from other journals.

* Related collections:
 Treatment
 Ablation/ICD/surgery
 Behavioral/psychosocial - treatment
 Cardiovascular Pharmacology
 Catheter-based coronary and valvular interventions: other
 Catheter-based coronary interventions: stents
 Compliance/Adherence
 CPR and emergency cardiac care
 Exercise/exercise testing/rehabilitation
 Pacemaker
 Primary prevention
 Restenosis
 Secondary prevention
 Other Treatment